Literature DB >> 10180513

Direct involvement of trabecular meshwork in the regulation of aqueous humor outflow.

M Wiederholt1.   

Abstract

Our new hypothesis for the regulation of aqueous humor outflow suggests that the trabecular meshwork is not a passive filter but an active contractile element contributing to the ciliary muscle traction affecting it. The trabecular meshwork contains contractile smooth-muscle-specific alpha-actin filaments, and its cells exhibit electrical properties typical for smooth muscle cells. Contractility measurements performed for the first time in isolated trabecular meshwork enable a functional comparison with ciliary muscle. Pharmacologic outflow regulation has been determined in isolated perfused anterior segments with intact trabecular meshwork and total absence of ciliary muscle. Substances that contracted isolated trabecular meshwork (e.g., pilocarpine) decreased the outflow rate, whereas relaxants (e.g., low-dose epinephrine) increased it. The concept of a functional antagonism between the trabecular meshwork and the ciliary muscle has to be considered.

Entities:  

Mesh:

Year:  1998        PMID: 10180513     DOI: 10.1097/00055735-199804000-00009

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  15 in total

1.  Characterization of cytoskeleton-enriched protein fraction of the trabecular meshwork and ciliary muscle cells.

Authors:  Toshihiro Inoue; Paula Pecen; Rupalatha Maddala; Nikolai P Skiba; Padmanabhan P Pattabiraman; David L Epstein; P Vasantha Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-14       Impact factor: 4.799

2.  Analyzing live cellularity in the human trabecular meshwork.

Authors:  Jose M Gonzalez; Sarah Hamm-Alvarez; James C H Tan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

3.  Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension.

Authors:  Luciano Quaranta; Raffaele Turano; Teodoro Pizzolante
Journal:  Clin Ophthalmol       Date:  2007-06

4.  Inhibition of RhoA signaling with increased Bves in trabecular meshwork cells.

Authors:  Patricia K Russ; Asher I Kupperman; Sai-Han Presley; Frederick R Haselton; Min S Chang
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

5.  Presence of an established calcification marker in trabecular meshwork tissue of glaucoma donors.

Authors:  Wei Xue; Núria Comes; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

6.  Cyclic mechanical stress and trabecular meshwork cell contractility.

Authors:  Renata F Ramos; Grant M Sumida; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-01       Impact factor: 4.799

7.  Cyp1b1 mediates periostin regulation of trabecular meshwork development by suppression of oxidative stress.

Authors:  Yun Zhao; Shoujian Wang; Christine M Sorenson; Leandro Teixeira; Richard R Dubielzig; Donna M Peters; Simon J Conway; Colin R Jefcoate; Nader Sheibani
Journal:  Mol Cell Biol       Date:  2013-08-26       Impact factor: 4.272

8.  Dexamethasone disrupts intercellular junction formation and cytoskeleton organization in human trabecular meshwork cells.

Authors:  Ye Hong Zhuo; Yuan He; Kar Wah Leung; Fei Hou; Yi Qing Li; Fang Chai; Jian Ge
Journal:  Mol Vis       Date:  2010-01-16       Impact factor: 2.367

9.  Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.

Authors:  Scott D Smid
Journal:  Clin Ophthalmol       Date:  2009-12-29

10.  Altered expression of transforming growth factor beta 1 and matrix metalloproteinase-9 results in elevated intraocular pressure in mice.

Authors:  Jennifer V Robertson; Anuja Siwakoti; Judith A West-Mays
Journal:  Mol Vis       Date:  2013-03-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.